Advocate Group’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-77,431
| Closed | -$8.68M | – | 122 |
|
|
2025
Q1 | $8.68M | Sell |
77,431
-2,014
| -3% | -$226K | 1.58% | 24 |
|
|
2024
Q4 | $7.34M | Buy |
79,445
+751
| +1% | +$69.4K | 1.38% | 33 |
|
|
2024
Q3 | $6.6M | Buy |
78,694
+1,044
| +1% | +$87.5K | 1.2% | 38 |
|
|
2024
Q2 | $5.33M | Buy |
77,650
+3,580
| +5% | +$246K | 1.07% | 42 |
|
|
2024
Q1 | $5.43M | Buy |
74,070
+2,146
| +3% | +$157K | 1.08% | 43 |
|
|
2023
Q4 | $5.83M | Buy |
71,924
+88
| +0.1% | +$7.13K | 1.25% | 32 |
|
|
2023
Q3 | $5.38M | Sell |
71,836
-1,071
| -1% | -$80.3K | 1.25% | 33 |
|
|
2023
Q2 | $5.62M | Sell |
72,907
-152
| -0.2% | -$11.7K | 1.24% | 32 |
|
|
2023
Q1 | $6.06M | Buy |
73,059
+1,406
| +2% | +$117K | 1.32% | 32 |
|
|
2022
Q4 | $6.15M | Buy |
71,653
+5,494
| +8% | +$472K | 1.32% | 31 |
|
|
2022
Q3 | $4.08M | Buy |
66,159
+12,767
| +24% | +$788K | 1.01% | 42 |
|
|
2022
Q2 | $3.3M | Buy |
+53,392
| New | +$3.3M | 0.77% | 49 |
|